Lung Cancer Treatment in India: Surgery, Targeted Therapy & Survival Outcomes (2026)

Are you looking for the best place to treat lung cancer without spending too much?

If yes, you're not alone.

“India”, in particular, has become a preferred country for lung cancer treatment because patients can access modern cancer care, experienced specialists, and advanced treatments at a lower cost. 

Every year, thousands of families look into lung cancer treatment in India for international patients after comparing hospitals, doctors, and treatment costs in different countries.

So, if you're comparing lung cancer surgery India cost or exploring NSCLC treatment India, this guide will help you understand. Here, we’ll learn the available treatments, expected costs of the treatments in 2026, and survival rates in a very simple language.

Understanding Lung Cancer: Types, Staging & Your Treatment Roadmap

NSCLC vs. SCLC: Key Differences

If you've just been diagnosed with lung cancer, you'll probably hear many new medical terms. Out of them, NSCLC or SCLC are common. The names may sound confusing to you. But they're simply the two main types of lung cancer. Let’s clear the difference:

Feature	NSCLC (Non-Small Cell Lung Cancer)	SCLC (Small Cell Lung Cancer)
How common is it?	Around 85% of lung cancer cases	Around 15% of cases
Growth rate	Usually grows more slowly	Often grows and spreads quickly
Surgery	Often possible if found early	Less commonly used
Common treatment	Surgery, immunotherapy, chemotherapy, radiation	Chemotherapy, immunotherapy and radiation are more common
Biomarker testing	Routinely recommended for advanced disease	Not routinely used in the same way
Overall outlook	Better if diagnosed early	Usually diagnosed at a more advanced stage

The good news is that treatment for both types has improved over the last few years. Even patients with advanced disease now have more options than before.

Stage I–IV Treatment Options Explained

The first step of starting a lung cancer treatment is making the right diagnosis because everything else - from surgery to targeted medicines - depends on it. 

Doctors first identify staging. That's because the stage tells how much the cancer has grown and whether it has spread beyond the lung.

Stage I:- If it's caught at Stage I, surgery is often enough to remove the tumour. Some patients may need extra treatment later, while others only need regular follow-ups.

Stage II or III:- By Stage II or III, things become a little more complicated. In this stage, you may be told to get surgery done in a combination with chemotherapy or radiation.

Stage IV:- In the Stage IV of lung cancer, the disease already spread to other parts of the body. That’s why, doctors usually focus on medicine treatment like targeted therapy (immunotherapy, or chemotherapy) to slow the disease and provide relief to the patients.

The Role of Biomarker Testing (EGFR, ALK, PD-L1)

For the past 5-10 years, doctors don’t want to stop after diagnosing that it's lung cancer. They usually want one more piece of information before deciding on treatment.

That's where biomarker testing comes in.

The biopsy sample is checked for things like

• EGFR,
• ALK,
• ROS1, and
• PD-L1

This test tell doctors whether targeted therapy or immunotherapy is likely to help.

For many people with advanced NSCLC, this test has become a normal part of the process. Most cancer hospitals in India do it before treatment begins because it gives the team a clearer idea of what is likely to work.

It doesn't change the diagnosis, but it can definitely change the treatment.

Why India Is a Leading Destination for Lung Cancer Treatment

Availability of All Targeted Therapy Drugs at 70% Less Cost

Lung cancer treatment has changed a lot over the last few years. 

Rather than of attacking both healthy and cancer cells, like chemotherapy does, these medicines are designed to target specific gene changes found in the tumour.

For patients with

EGFR,

ALK,

ROS1,

BRAF,

MET,

RET, or

KRAS G12C mutations,

doctors may recommend targeted drugs if the biomarker test shows they can be effective. 

The good news is that almost all major targeted therapy medicines approved internationally are available in India. This includes both branded medicines and, where permitted, lower-cost generic versions. The biggest advantage, however, is the price.

Many of these medicines cost [50% to 70% less in India] than they do in countries like the USA or the UK. That's one of the reasons patients researching EGFR mutation targeted therapy India often choose to travel here for treatment.

Of course, not every patient is eligible for targeted therapy. Your doctor will first recommend molecular testing to find out whether your tumour has a treatable genetic mutation.

Experienced Thoracic Oncology Teams

First of all, a surgeon checks if the tumour is safely removable or not. After that, a medical oncologist decides if you need chemotherapy, immunotherapy, or any particular targeted therapy. A radiation oncologist plans radiation treatment if required.

Then there are pulmonologists, radiologists and pathologists.

The team may also include pulmonologists, radiologists, and pathologists, who each play an important role in your diagnosis and treatment. These specialists don't work separately. They discuss the case together before deciding on a treatment plan.

This is called a “multidisciplinary tumour board”.

Discussing the case together helps the team decide what is best for the patient.

Many hospitals in India follow this approach for both early-stage and advanced lung cancer.

This is especially helpful for people looking for NSCLC treatment India, where treatment decisions often depend on biopsy findings, PET-CT scans and biomarker reports - not just the size of the tumour.

For international patients, there's another advantage. Most leading cancer centres have international patient teams that coordinate appointments, investigations and treatment under one roof. That means less running around after arriving in India. 

No Waiting Lists for Surgery

After being diagnosed with lung cancer, most people want to begin their treatment as soon as possible. Because waiting can only make it dangerous.

In many leading private hospitals, surgeries are most likely to be scheduled soon after the necessary tests, like scans, biopsy, biomarker testing, are completed. Though, the exact timing depends on your condition, the stage of the cancer, and the hospital's schedule.

But, long waiting lists are generally less common than in several public healthcare systems.

If you're considering lung cancer treatment in India for international patients, faster access to surgery is one of the practical advantages many hospitals offer.

Lung Cancer Treatment Costs in India (2026 Breakdown)

VATS (keyhole) Surgery: $8,000–$12,000

If your doctor has told you that they’ll have to do “surgery” to treat your cancer, the chances are you may be recommend Video-Assisted Thoracoscopic Surgery (VATS). It’s also known as “keyhole lung surgery.

Rather than making one large cut in the chest, the surgeon performs the procedure through a few small openings using a camera and specialised instruments.

Now, you might be wondering: Why do many patients prefer VATS?

• Smaller cuts
• Less pain after surgery
• Shorter hospital stay
• Faster recovery in many cases

Of course, it isn't suitable for everyone. The size of the tumour, where it's located, and whether it has spread all play a role. In some situations, doctors may still recommend traditional open surgery.

Now let's talk about the cost.

The lung cancer surgery India cost for VATS usually falls between USD 8,000 and USD 12,000. But, keep in mind that this isn't a fixed price. Some hospitals may charge a little less, while others may charge more depending on the complexity of the surgery.

In most cases, the package includes:

• Surgeon's fee
• Anaesthesia
• Operation theatre charges
• Standard investigations
• Hospital stay
• Nursing care

You should also ask the hospital what isn't included. Medicines after discharge, extra investigations, ICU stay, or unexpected complications can increase the overall cost.

Even after including travel expenses, many international patients still find India much more affordable than countries like the USA or the UK. That's one of the main reasons people from Africa, the Middle East, and CIS countries choose India for lung cancer surgery. 

Chemotherapy Per Cycle Cost Comparison

Many lung cancer patients, especially those with advanced disease, receive chemotherapy. Sometimes it's the main treatment. In other cases, it's given before or after surgery. It can also be combined with immunotherapy or radiation, depending on the stage of the cancer.

So, how much does it cost?

The number of treatment cycles varies from one patient to another. Still, the average cost per cycle looks something like this.

Country	Average Cost Per Cycle
India	USD 500-2,000
USA	USD 5,000-12,000+
UK (Private)	USD 3,500-8,000

That's quite a difference.

For many international patients, this is one of the biggest reasons they start looking at treatment in India. Even after paying for flights and accommodation, the total expense can still be much lower than having the same treatment in many other countries.

One thing I'd always suggest is asking the hospital exactly what's included in the estimate. Some hospitals include the medicines, doctor's consultation, and day-care charges together. Others bill each of them separately.

If you're comparing the NSCLC treatment India cost or trying to estimate the SCLC treatment India cost, don't compare only the price of one chemotherapy session. Look at the expected cost of the complete treatment plan. That's the number that really matters. 

Immunotherapy (Pembrolizumab) Price in India vs. USA

Not every lung cancer patient receives immunotherapy.

Before suggesting medicines like Pembrolizumab (Keytruda), doctors usually check whether the tumour is likely to respond. That's where PD-L1 testing becomes important. If the results are favourable, immunotherapy may be used on its own or together with chemotherapy.

Now comes the part most families worry about - the “cost”.

First comes “Pembrolizumab”, one of the most effective immunotherapy drugs available today.  But, it's also one of the most expensive. In the U.S.A, the official list price for one 200 mg treatment is USD 12,272, and that doesn't include hospital charges, and other costs.

The price in India is much lower. To make it easier, here's a simple price comparison.

Country	Approximate Price
India (100 mg vial)	₹1.5 lakh+ (USD 1,700-1,900)
USA (200 mg treatment)	USD 12,272 (list price)

One thing that's easy to miss is that the medicine itself isn't the whole bill.

Patients may also need blood tests, doctor's consultations, day-care charges, scans, and medicines to manage side effects. 

You may also have to pay for

• blood tests,
• doctor visits,
• scans,
• day-care charges, and
• medicines to help manage side effects.

This is why treatment costs can be different, even two people taking the same medicine.

If you're planning lung cancer treatment in India for international patients, you should ask the hospital for a detailed cost estimate after your reports have been reviewed.

Top Hospitals for Lung Cancer Treatment in India

Artemis Hospital, Gurugram

Many international patients looking for lung cancer treatment in India starts the procedure by comparing hospitals in the Delhi-NCR region first. When they do, “Artemis Hospital” is one of the names that regularly comes up during that search, especially for patients who need surgery, targeted therapy, or a combo.

The hospital treats both NSCLC and SCLC patients and sees cases across different stages of the disease. Some people arrive with a small tumour that can be removed through surgery. 

On the other hand, some come after being diagnosed with advanced cancer and need a combination of targeted therapy, immunotherapy, chemotherapy, or radiation treatment.

Here, everything, such as Imaging, biopsy procedures, molecular testing, surgery, medical oncology, and radiation therapy can all be coordinated through a single team.

Notable features at Artemis Hospital include:

• Dedicated cancer center
• Thoracic surgery services
• PET-CT and advanced imaging facilities
• Molecular and biomarker testing
• Bronchoscopy and Lung Biopsy
• Radiation oncology services
• Immunotherapy and targeted therapy programs
• International patient support team.

For patients with advanced NSCLC, doctors may suggest molecular testing to check for gene changes such as EGFR, ALK, ROS1, and other important biomarkers. These test results help doctors decide whether targeted therapy may work better than regular chemotherapy.

Imp: The hospital also treats patients from Africa, the Middle East, Bangladesh, and CIS countries. To make the treatment journey easier, it provides support with medical visa applications, travel arrangements, language interpretation, and accommodation bookings. 

For lung cancer treatment in India for international patients, Artemis is definitely considered because it provides surgery, radiation oncology, medical oncology, and diagnostic services; all under one roof.

Max Institute of Cancer Care, Delhi

Max Institute of Cancer Care (MICC) is one of India's largest cancer networks with hospitals present in Delhi (Saket, Patparganj, Shalimar Bagh), Ghaziabad (Vaishali), Mohali, and Bathinda. It is widely recognized for its specialized oncology programs.

The hospital sees a large number of lung cancer cases every year. Some patients come in at an early stage when surgery may be an option, while others need treatment for advanced cancer.

Doctors from different specialties work together during the treatment process. This helps patients get opinions and care from multiple experts without having to visit different hospitals. 

Notable things you’ll find in Max Institute of Cancer Care:

• Over 100 oncologists
• Dedicated thoracic oncology units
• Comprehensive molecular testing
• Advanced radiation therapy platforms
• Surgical oncology expertise
• Intensive care support
• International patient programs

The institute routinely treats patients requiring complex treatment combinations such as:

- Surgery followed by chemotherapy

- Chemoradiation

- Immunotherapy-based treatment

- Targeted therapy for molecularly selected tumors

Patients seeking advanced NSCLC treatment India options often undergo biomarker-driven treatment planning at specialized centers such as Max.

HCG Oncology Centres, Mumbai

For those looking for lung cancer surgery India cost, HCG Oncology Centres remains a recognized option for them, particularly for those seeking personalized treatment plans and advanced facilities.

Not every patient wants treatment at a large multispecialty hospital. Some specifically look for hospitals where cancer care is the primary focus. That's one reason HCG Oncology Centres often comes up during the research process.

HCG operates as a dedicated cancer care network, and its Mumbai centre treats a wide range of thoracic cancers, including both NSCLC and SCLC. Patients are typically evaluated by specialists who work exclusively in oncology rather than across multiple departments.

Some of the key services available for lung cancer patients include:

• Lung cancer screening and diagnosis
• Molecular and biomarker testing
• Thoracic surgical oncology
• Chemotherapy services
• Radiation oncology
• Immunotherapy treatment
• Targeted therapy programs
• Supportive and palliative care

Treatment at HCG often begins with understanding the tumour’s biology. Biomarker testing helps identify patients who may benefit from targeted treatments. This is especially important for people exploring EGFR-targeted therapy options in India.

Many patients also visit HCG for a second opinion after receiving treatment elsewhere. In advanced lung cancer cases, a fresh review can sometimes reveal additional treatment options.

As a dedicated cancer hospital, HCG provides diagnostic, medical, surgical, and radiation oncology services under one network, making cancer care more coordinated and convenient. 

Survival Rates & Advances in Lung Cancer Care

Survival rates give you an idea about how people with a similar type of cancer have responded to treatment over time. Remember, although these data offer a general picture, they cannot tell you exactly what your future will look like.

5-year Survival Rates by Stage

The 5-year relative survival rate is a way of comparing the survival of people with a certain type of cancer to that of people in the general population.

For Example: Let’s say a stage of lung cancer has a 5-year relative survival rate of 70%, it means that people diagnosed with that cancer are, on average, around 70% as likely to live for at least five years as those who do not have the disease.

Most importantly, the patients that have diagnosed the cancer earlier tend to have better outcomes. That's because treatment can begin before the cancer has spread extensively.

Non-Small Cell Lung Cancer (NSCLC):

Stage	Approximate 5-Year Survival Rate
Stage I	70%–90%
Stage II	50%–65%
Stage III	25%–40%
Stage IV	10%–25%

The difference between Stage I and Stage IV is significant. In Stage I, surgery may remove all visible cancer. In Stage IV, treatment is usually focused on controlling the disease for as long as possible. Plus, the guarantee of recovery is also reduced in the later stages.

That said, doctors are seeing outcomes today that would have been difficult to imagine years ago. Some patients with advanced NSCLC continue working, travelling, and living relatively normal lives while receiving treatment.

Small Cell Lung Cancer (SCLC):

Stage	Approximate 5-Year Survival Rate
Limited Stage	20%-35%
Extensive Stage	3%-10%

Small Cell Lung Cancer is generally more aggressive than NSCLC. Even so, treatment approaches continue to improve, particularly with the addition of immunotherapy in selected patients. 

Key Note: These numbers are calculated using data from large groups of patients who were diagnosed in the past. Since every person’s health, treatment response, and medical history are different, survival statistics should only be used as a guide.

They are not a prediction of what will happen in your case. If you are unsure about what these figures mean, your doctor can explain how they relate to your individual situation.

Liquid Biopsy for Monitoring Treatment Response

Doctors usually monitor lung cancer treatment using CT scans, PET scans, and regular clinical check-ups. While these tests are still very important, another tool is becoming more common in advanced lung cancer care: “liquid biopsy”.

In this method, rather than removing a piece of the tumour, a liquid biopsy only requires a blood sample. The test looks for tiny fragments of tumour DNA (called circulating tumour DNA or ctDNA) that are released into the bloodstream. 

Doctors may recommend a liquid biopsy to:

• Check whether targeted therapy is still working
• Detect new genetic mutations that develop during treatment
• Find out why a targeted drug has stopped working
• Help decide whether it's time to switch to another treatment

For ex: Many patients who are receiving EGFR mutation targeted therapy India respond very well in the beginning. But, some tumours later may develop new mutations which make the original medicine less effective. A liquid biopsy can help detect these changes without requiring another lung biopsy.

Another advantage is that the test is much less invasive. This can be helpful for patients whose tumours are difficult to reach or who are not fit enough for another tissue biopsy.

Today, several leading cancer hospitals in India use liquid biopsy alongside conventional imaging for selected patients with lung cancer surgery India cost.

Although it does not replace the first tissue biopsy used to diagnose lung cancer, it has become an important tool for monitoring treatment response and planning the next step in care.

Personalised Cancer Vaccines — What's Coming in 2026

Cancer treatment continues to evolve every year. One area that researchers are especially excited about is personalised cancer vaccines.

Unlike vaccines that prevent infections, these vaccines are designed to help the body's immune system recognise and attack cancer cells that are already present.

Here's how the process works:

• Doctors analyse the patient's tumour after surgery or biopsy.
• They identify unique genetic changes found only in that tumour.
• A vaccine is then developed to train the immune system to recognise those specific cancer cells.
• The goal is to help the immune system destroy any remaining cancer cells and reduce the chances of the disease returning.

Are they available in 2026?

Not yet as a routine treatment. However, several early clinical trials are studying personalised mRNA cancer vaccines in patients with Non-Small Cell Lung Cancer (NSCLC).

Researchers are also testing them alongside immunotherapy to see whether the combination produces a stronger and longer-lasting response.

Although these vaccines are not yet a standard treatment in 2026, the early results have been encouraging. Experts believe they could become an additional treatment option in the coming years, particularly for patients whose tumours have specific genetic features.

For patients considering lung cancer treatment in India for international patients, it's worth knowing that many leading cancer centres already participate in international clinical research and continue to adopt new treatment approaches as evidence becomes available.

Key Takeaway: The future of lung cancer treatment is becoming more personalised. Instead of using the same treatment, doctors are now choosing therapies based on the biology of each person's cancer, which is a trend that is expected to improve survival outcomes even further.

Frequently Asked Questions

What is the success rate of lung cancer treatment in India?

The success rate of lung cancer treatment in India completely depends on the cancer stage. People diagnosed at an early stage, especially Stage I, generally have a much better outlook. In many cases, the five-year survival rate ranges from 56% to as high as 90%. Someone with late-stage (e.g.,Stage IV), the 5-year survival drops huge to around 3% to 8%.

How much does lung cancer surgery cost in India?

Lung cancer treatment in India for international patients typically costs between INR 3,00,000 to INR 12,00,000 ($3,500 to $15,000 USD). This is an estimate and it usually covers the surgery, anesthesia, standard pre-operation diagnostics, and a few days of hospital stay. But, the actual cost is not fixed as it varies depending on patients, hospitals, and several other things.

Disclaimer: This article is for informational purposes only and does not constitute medical advice.